Aurobindo, Hetero, and Vivimed Class Action Settlements in Maryland

All Aurobindo, Hetero, and Vivimed class action lawsuits and settlements available to Maryland residents.

Maryland residents have 1 active class action settlements involving Aurobindo, Hetero, and Vivimed that they can file claims for right now. Open settlements include $15.2M Valsartan, Losartan and Irbesartan class action settlement.

Class Action Buddy automatically files Aurobindo, Hetero, and Vivimed claims for Maryland residents in under 60 seconds — no paperwork, no mailing, no proof of purchasey/proof-of-purchase/" style="color:#5D82F2;text-decoration:none;font-weight:500;">proof of purchase needed for most settlements.

About Aurobindo, Hetero, and Vivimed Class Actions in Maryland

Maryland residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed may be eligible for compensation through the $15.2 million valsartan, losartan, and irbesartan class action settlement. These Indian pharmaceutical manufacturers distributed contaminated generic medications throughout the United States, including Maryland's healthcare system. Maryland's Consumer Protection Act provides additional safeguards for residents, allowing for potential treble damages in cases of unfair or deceptive trade practices involving pharmaceuticals. The state's proximity to major East Coast distribution hubs means many Maryland pharmacies received these contaminated medications. Generic drug manufacturers like these three companies supply approximately 90% of prescriptions filled in Maryland through major pharmacy chains and independent pharmacies. Maryland residents filing class action claims must be aware that the state follows a three-year statute of limitations for personal injury claims, though discovery rules may extend this timeframe. The Maryland Attorney General's office has been active in pharmaceutical litigation, providing additional oversight for residents affected by contaminated medications distributed by these manufacturers.

What makes Maryland residents eligible for the Aurobindo, Hetero, and Vivimed settlement?

Maryland residents who took valsartan, losartan, or irbesartan manufactured by these companies between 2012-2018 may qualify for the $15.2 million settlement. Eligibility requires proof of prescription fills from Maryland pharmacies that dispensed the contaminated medications. Medical documentation showing adverse effects or cancer diagnoses may increase compensation amounts.

How does Maryland's Consumer Protection Act affect claims against these pharmaceutical companies?

Maryland's Consumer Protection Act allows residents to seek additional damages beyond the class action settlement for deceptive trade practices. This state law provides stronger consumer protections than federal regulations alone. Maryland residents may pursue individual claims while participating in the class action settlement.

Are there specific deadlines for Maryland residents to file claims against Aurobindo, Hetero, and Vivimed?

Maryland follows a three-year statute of limitations for personal injury claims, but the discovery rule may extend this deadline for contaminated medication cases. The class action settlement has specific filing deadlines that override state statutes. Maryland residents should file claims promptly to preserve all legal options under both state and federal law.

Tips for Maryland Residents Filing Aurobindo, Hetero, and Vivimed Claims

Maryland residents should gather prescription records from all pharmacies where they filled valsartan, losartan, or irbesartan prescriptions between 2012-2018. Contact your pharmacy to identify the manufacturer of your specific generic medication, as multiple companies produced these drugs. Keep detailed medical records documenting any adverse health effects or cancer diagnoses following use of these medications. Consider consulting with Maryland attorneys experienced in pharmaceutical litigation, as state consumer protection laws may provide additional compensation beyond the class action settlement. File claims before deadlines expire and maintain copies of all documentation submitted.

More Maryland Resources